Literature DB >> 10712475

Functional expression of three P2X(2) receptor splice variants from guinea pig cochlea.

C Chen1, M S Parker, A P Barnes, P Deininger, R P Bobbin.   

Abstract

ATP has been suggested to act as a neurotransmitter or a neuromodulator in the cochlea. The responses to ATP in different cell types of the cochlea vary in terms of the rate of desensitization and magnitude, suggesting that there may be different subtypes of P2X receptors distributed in the cochlea. Recently three ionotropic P2X(2) receptor splice variants, P2X(2-1), P2X(2-2), and P2X(2-3,) were isolated and sequenced from a guinea pig cochlear cDNA library. To test the hypothesis that these different splice variants could be expressed as functional homomeric receptors, the three P2X(2) receptor variants were individually and transiently expressed in human embryonic kidney cells (HEK293). The biophysical and pharmacological properties of these receptors were characterized using the whole cell patch-clamp technique. Extracellular application of ATP induced an inward current in HEK293 cells containing each of the three splice variants in a dose-dependent manner indicating the expression of homomeric receptors. Current-voltage (I-V) relationships for the ATP-gated current show that the three subtypes of the P2X(2) receptor had a similar reversal potential and an inward rectification index (I(50 mV)/I(-50 mV)). However, the ATP-induced currents in cells expressing P2X(2-1) and P2X(2-2) variants were large and desensitized rapidly whereas the current in those cells expressing the P2X(2-3) variant was much smaller and desensitized slower. The order of potency to ATP agonists was 2-MeSATP > ATP > alpha,beta -MeATP for all three expressed splice variants. The ATP receptor antagonists suramin and PPADS reduced the effects of ATP on all three variants. Results demonstrate that three P2X(2) splice variants from guinea pig cochlea, P2X(2-1), P2X(2-2), and P2X(2-3), can individually form nonselective cation receptor channels when these subunits are expressed in HEK293 cells. The distinct properties of these P2X(2) receptor splice variants may contribute to the differences in the response to ATP observed in native cochlear cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712475     DOI: 10.1152/jn.2000.83.3.1502

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  8 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 3.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

5.  Multiple P2X receptors on guinea-pig pelvic ganglion neurons exhibit novel pharmacological properties.

Authors:  Y Zhong; P M Dunn; G Burnstock
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

7.  Mouse Leydig cells express multiple P2X receptor subunits.

Authors:  Ligia Subitoni Antonio; Roberta Ribeiro Costa; Marcelo Damário Gomes; Wamberto Antonio Varanda
Journal:  Purinergic Signal       Date:  2008-11-20       Impact factor: 3.765

8.  The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs.

Authors:  Yalda Moayedi; Martin L Basch; Natasha L Pacheco; Simon S Gao; Rosalie Wang; Wilbur Harrison; Ningna Xiao; John S Oghalai; Paul A Overbeek; Graeme Mardon; Andrew K Groves
Journal:  PLoS Genet       Date:  2014-01-02       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.